Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Rana Muhammad Awais Khan"'
Publikováno v:
Global Drug Design & Development Review. :13-29
mmune system mediates the tumor progression as the protective actions of the immune cells are suppressed, and they assist the tumor to grow by various mechanisms. This review illustrates the mechanisms adapted by the T regulatory cells, T helper cell
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4ffdf7dfbc33104026a38da29f0f96e3
https://doi.org/10.31703/gdddr.2021(vi-iv).02
https://doi.org/10.31703/gdddr.2021(vi-iv).02
Publikováno v:
Global Drug Design & Development Review. :25-32
This review illustrates a comparison of currently implemented strategies and the need of a novel technique to cure the COVID-19. Current strategies served a lot to cope up with the situation by decreasing the rate of fatalities i.e. some FDA approved
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::56b776869a25d98e1b65677749835aaa
https://doi.org/10.31703/gdddr.2020(v-i).03
https://doi.org/10.31703/gdddr.2020(v-i).03
Publikováno v:
Global Pharmaceutical Sciences Review. :19-26
Biological half-life and volume of distribution of the drug are the key parameters in understanding the pharmacokinetics of the drugs within the body as they affect all the pharmacokinetic processes including absorption, distribution, metabolism and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d0ffdfab60a51ba7299c52a58a5027eb
https://doi.org/10.31703/gpsr.2018(iii-i).03
https://doi.org/10.31703/gpsr.2018(iii-i).03
Publikováno v:
Global Drug Design & Development Review. :23-30
Triamcinolone acetonide is an antiinflammatory drug that has been used for more than 50 years for the treatment of various inflammatory disorders including the arthritis & gout etc. Moreover, in recent years its use has been rapidly increased for the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5d3cb1449b3966c01544c6f00be16bfc
https://doi.org/10.31703/gdddr.2018(iii-i).04
https://doi.org/10.31703/gdddr.2018(iii-i).04